Page last updated: 2024-11-07

4-(1-(1-naphthyl)ethyl)imidazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-(1-(1-naphthyl)ethyl)imidazole: InChIKey: DZSQSLQSMKNVBV-UHFFFAOYSA-N [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID132110
CHEMBL ID541105
SCHEMBL ID9736744
MeSH IDM0197996

Synonyms (20)

Synonym
4-(1-(1-naphthyl)ethyl)imidazole
CHEMBL541105 ,
4-(1-(1-naphthyl)ethyl)imidazole hcl
1h-imidazole, 4-(1-(1-naphthalenyl)ethyl)-, monohydrochloride
unii-285367936d
4-(1-(1-naphthyl)ethyl)imidazole hydrochloride
4-nemd
285367936d ,
137967-81-8
SCHEMBL9736744
4-(1-naphthalen-1-ylethyl)imidazole hydrochloride
1h-imidazole, 5-(1-(1-naphthalenyl)ethyl)-, hydrochloride (1:1)
5-(1-(1-naphthalenyl)ethyl)-1h-imidazole, hydrochloride
1h-imidazole, 4-(1-(1-naphthalenyl)ethyl)-, hydrochloride
naphthylmedetomidine hydrochloride
Q27895552
DTXSID30929957
5-(1-naphthalen-1-ylethyl)-1h-imidazole;hydrochloride
bdbm50230389
1h-imidazole,5-[1-(1-naphthalenyl)ethyl]-,hydrochloride(1:1)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID36187Compound was tested for Adrenergic activity against Alpha-2 adrenergic receptor from rat aorta1992Journal of medicinal chemistry, Feb-21, Volume: 35, Issue:4
Synthesis and alpha-adrenergic activities of 2- and 4-substituted imidazoline and imidazole analogues.
AID186232Percent maximal analogue response relative to phenylephrine =100%1992Journal of medicinal chemistry, Feb-21, Volume: 35, Issue:4
Synthesis and alpha-adrenergic activities of 2- and 4-substituted imidazoline and imidazole analogues.
AID226745Potency ratio is defined as IC50(medetomidine)/IC50(compound)1992Journal of medicinal chemistry, Feb-21, Volume: 35, Issue:4
Synthesis and alpha-adrenergic activities of 2- and 4-substituted imidazoline and imidazole analogues.
AID226744Potency ratio is defined as EC50 (medetomidine) / EC50 (compound)1992Journal of medicinal chemistry, Feb-21, Volume: 35, Issue:4
Synthesis and alpha-adrenergic activities of 2- and 4-substituted imidazoline and imidazole analogues.
AID36581Compound was evaluated for Adrenergic activity against Alpha-1 adrenergic receptor from rat aorta1992Journal of medicinal chemistry, Feb-21, Volume: 35, Issue:4
Synthesis and alpha-adrenergic activities of 2- and 4-substituted imidazoline and imidazole analogues.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.28 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (16.67%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]